Why did Metaplanet's Bitcoin holdings surge?
How is the Israel-Iran conflict impacting oil prices?
What caused Uber and unions to settle driver wage dispute?
Why is Trump launching a mobile phone company?
How did Trump's approval affect U.S. Steel's stock?
What explains AMD's recent stock rally?
Why are WhatsApp ads now rolling out?
Eli Lilly Launches Flat Pricing For Zepbound, Capping Monthly Cost At $499
benzinga.com/news/health-care/25/06/45947852/eli-lilly-launches-flat-pricing-for-zepbound-capping-monthly-cost-at-499
Eli Lilly And Co (NYSE:LLY) announced on Monday that the highest approved doses of Zepbound (tirzepatide)—12.5 mg and 15 mg—would soon be available in single-dose vials for $499 per month through LillyDirect’s Self Pay Pharmacy Solutions and the Zepbound Self Pay Journey…
This story appeared on benzinga.com, 2025-06-16 12:53:40.